Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 5
2018 11
2019 11
2020 26
2021 26
2022 27
2023 28
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Pelaia C, et al. Front Immunol. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312. eCollection 2020. Front Immunol. 2020. PMID: 33329598 Free PMC article. Review.
Tezepelumab for asthma.
Nolasco S, Pelaia C, Scioscia G, Campisi R, Crimi C. Nolasco S, et al. Among authors: pelaia c. Drugs Today (Barc). 2022 Dec;58(12):591-603. doi: 10.1358/dot.2022.58.12.3449205. Drugs Today (Barc). 2022. PMID: 36651067 Review.
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.
Siciliano MA, Caridà G, Ciliberto D, d'Apolito M, Pelaia C, Caracciolo D, Riillo C, Correale P, Galvano A, Russo A, Barbieri V, Tassone P, Tagliaferri P. Siciliano MA, et al. Among authors: pelaia c. ESMO Open. 2022 Jun;7(3):100465. doi: 10.1016/j.esmoop.2022.100465. Epub 2022 Apr 12. ESMO Open. 2022. PMID: 35427835 Free PMC article.
Switching Biological Therapies in Severe Asthma.
Scioscia G, Nolasco S, Campisi R, Quarato CMI, Caruso C, Pelaia C, Portacci A, Crimi C. Scioscia G, et al. Among authors: pelaia c. Int J Mol Sci. 2023 May 31;24(11):9563. doi: 10.3390/ijms24119563. Int J Mol Sci. 2023. PMID: 37298514 Free PMC article. Review.
Dupilumab for the treatment of asthma.
Pelaia C, Vatrella A, Gallelli L, Terracciano R, Navalesi P, Maselli R, Pelaia G. Pelaia C, et al. Expert Opin Biol Ther. 2017 Dec;17(12):1565-1572. doi: 10.1080/14712598.2017.1387245. Epub 2017 Oct 8. Expert Opin Biol Ther. 2017. PMID: 28990423 Review.
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis.
Pelaia C, Pelaia G, Maglio A, Tinello C, Gallelli L, Lombardo N, Terracciano R, Vatrella A. Pelaia C, et al. J Clin Med. 2023 May 9;12(10):3371. doi: 10.3390/jcm12103371. J Clin Med. 2023. PMID: 37240477 Free PMC article. Review.
Interleukin-5 in the Pathophysiology of Severe Asthma.
Pelaia C, Paoletti G, Puggioni F, Racca F, Pelaia G, Canonica GW, Heffler E. Pelaia C, et al. Front Physiol. 2019 Dec 17;10:1514. doi: 10.3389/fphys.2019.01514. eCollection 2019. Front Physiol. 2019. PMID: 31920718 Free PMC article. Review.
Novel Biological Therapies for Severe Asthma Endotypes.
Pelaia C, Pelaia G, Crimi C, Maglio A, Stanziola AA, Calabrese C, Terracciano R, Longhini F, Vatrella A. Pelaia C, et al. Biomedicines. 2022 May 4;10(5):1064. doi: 10.3390/biomedicines10051064. Biomedicines. 2022. PMID: 35625801 Free PMC article. Review.
Biologics in severe asthma.
Pelaia C, Pelaia G, Crimi C, Longhini F, Lombardo N, Savino R, Sciacqua A, Vatrella A. Pelaia C, et al. Minerva Med. 2022 Feb;113(1):51-62. doi: 10.23736/S0026-4806.21.07296-7. Epub 2021 Feb 8. Minerva Med. 2022. PMID: 33555158 Free article.
126 results